These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28034566)

  • 1. Erratum to "Biparametric 3t magnetic resonance imaging for prostatic cancer detection in a biopsy-naïve patient population: A further improvement of PI-RADS v2? [Eur. J. Radiol. 85 (12) (2016) 2269-2274]".
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2017 Feb; 87():125. PubMed ID: 28034566
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
    Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
    BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
    Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
    Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.
    Auer T; Edlinger M; Bektic J; Nagele U; Herrmann T; Schäfer G; Aigner F; Junker D
    World J Urol; 2017 May; 35(5):687-693. PubMed ID: 27510762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.
    Rosenkrantz AB; Oto A; Turkbey B; Westphalen AC
    AJR Am J Roentgenol; 2016 Jun; 206(6):1179-83. PubMed ID: 26913638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.
    Osses DF; van Asten JJ; Kieft GJ; Tijsterman JD
    World J Urol; 2017 Feb; 35(2):207-212. PubMed ID: 27287889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.
    Renard-Penna R; Mozer P; Cornud F; Barry-Delongchamps N; Bruguière E; Portalez D; Malavaud B
    Radiology; 2015 May; 275(2):458-68. PubMed ID: 25599415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
    Rastinehad AR; Waingankar N; Turkbey B; Yaskiv O; Sonstegard AM; Fakhoury M; Olsson CA; Siegel DN; Choyke PL; Ben-Levi E; Villani R
    PLoS One; 2015; 10(11):e0143404. PubMed ID: 26605548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.
    Hamoen EHJ; de Rooij M; Witjes JA; Barentsz JO; Rovers MM
    Eur Urol; 2015 Jun; 67(6):1112-1121. PubMed ID: 25466942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
    Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
    Eur J Radiol; 2020 Dec; 133():109417. PubMed ID: 33229110
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
    Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
    World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes of screening breast MRI with practice evolution: initial clinical experience with 3T compared to 1.5T.
    Lourenco AP; Donegan L; Khalil H; Mainiero MB
    J Magn Reson Imaging; 2014 Mar; 39(3):535-9. PubMed ID: 23720144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
    Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
    Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer.
    Kaufmann S; Bedke J; Gatidis S; Hennenlotter J; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Kruck S
    World J Urol; 2016 Apr; 34(4):509-15. PubMed ID: 26267808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a new PI-RADS v2-based nomogram for forecasting high-grade prostate cancer.
    Niu XK; He WF; Zhang Y; Das SK; Li J; Xiong Y; Wang YH
    Clin Radiol; 2017 Jun; 72(6):458-464. PubMed ID: 28069159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.
    Muller BG; Shih JH; Sankineni S; Marko J; Rais-Bahrami S; George AK; de la Rosette JJ; Merino MJ; Wood BJ; Pinto P; Choyke PL; Turkbey B
    Radiology; 2015 Dec; 277(3):741-50. PubMed ID: 26098458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.
    Grey AD; Chana MS; Popert R; Wolfe K; Liyanage SH; Acher PL
    BJU Int; 2015 May; 115(5):728-35. PubMed ID: 25041307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.